Dexmethylphenidate

Structural formula
General
Non-proprietary name	Dexmethylphenidate
other names	(2 R , 2 ′ R ) methylphenidate; D - (+) - methylphenidate; D -threo-methylphenidate; d-TMP; Latin : Dexmethylphenidatum;
Molecular formula	C 14 H 19 NO 2
Brief description	white powder (dexmethylphenidate hydrochloride)
External identifiers / databases
PubChem	154101
DrugBank	DB06701
Wikidata	Q1207210
Drug information
ATC code	N06 BA11
Drug class	Sympathomimetic; stimulant;
Mechanism of action	Dopamine reuptake inhibitors
properties
Molar mass	233.31 g · mol -1 (dexmethylphenidate) ; 269.77 g · mol -1 (Dexmethylphenidathydrochlorid) ;
Physical state	firmly
solubility	soluble in water (dexmethylphenidate hydrochloride)
safety instructions
	Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS hazard labeling ; no classification available
	As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Dexmethylphenidate is a drug with a stimulating effect . It is the pharmacologically active (2 R , 2 ′ R ) enantiomer of methylphenidate and, like the racemic form, is used to treat attention deficit / hyperactivity disorder (ADD / ADHD), but in halved dosage.

Finished medicinal products

Focalin XR ( CH , USA )

Dexmethylphenidate is available as sustained-release tablets in strengths of 5 mg to 20 mg (Switzerland) or up to 40 mg (USA). The water-soluble dexmethylphenidate hydrochloride is used in the manufacture of drugs .

Web links

Description of the substance dexmethylphenidate. University of Hamburg

Individual evidence

↑ ^a ^b Entry on dexmethylphenidate in the Pharmawiki , accessed on September 19, 2011.
↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
↑ Technical information on Focalin XR capsules, as of August 2009.

[wiki-1] Entry on dexmethylphenidate in the Pharmawiki , accessed on September 19, 2011.

[NV-2] This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.

[3] Technical information on Focalin XR capsules, as of August 2009.